Paladin Wealth’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
CRM
VNIM
CNB
Paladin Wealth's LLY Position: Q2 2026 in Review
Paladin Wealth increased its Eli Lilly (LLY) stake by 38% in Q2 2026, buying an estimated $192K and bringing the position to 677 shares worth $812K. The position accounts for 0.47% of the portfolio, ranked #64.
Paladin Wealth first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Paladin Wealth held 677 shares of Eli Lilly worth $812K as of Q2 2026.
- Paladin Wealth bought 188 Eli Lilly shares in Q2 2026, an estimated $192K.
- Eli Lilly made up 0.47% of Paladin Wealth's portfolio in Q2 2026, its #64 holding.
- Paladin Wealth first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
- 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Paladin Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.